Brief: Aura Biosciences Reports Q4 And Full Year 2022 Financial Results And Provides Clinical Development And Operational Highlights
15/03/2023 20:13
March 15 (Reuters) - Aura Biosciences Inc AURA.O :
* AURA BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS AND PROVIDES CLINICAL DEVELOPMENT AND
OPERATIONAL HIGHLIGHTS
Source text for Eikon: ID:nBw3wywvga
Further company coverage: AURA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aura Biosciences
See all newsBrief: Aura Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Aura Biosciences - May Offer Securities Up To $500 Million Aggregate
Brief: Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Aura Biosciences Q1 net loss widens on higher R&D costs